B cells and antibodies in CNS demyelinating disease

被引:180
|
作者
Cross, AH [1 ]
Trotter, JL [1 ]
Lyons, JA [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
关键词
multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody;
D O I
10.1016/S0165-5728(00)00409-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [1] Recruitment of endogenous CNS stem cells for regeneration in demyelinating disease
    Murphy, Natalia A.
    Franklin, Robin J. M.
    FUNCTIONAL NEURAL TRANSPLANTATION IV: TRANSLATION TO CLINICAL APPLICATION, PT B, 2017, 231 : 135 - 163
  • [2] Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease
    Brown, Melissa A.
    Weinberg, Rebecca B.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] Infection with B. burgdorferi s.l., and the CNS demyelinating disease
    Durovska, Judita
    Bazovska, Sylvia
    Pancak, Jaroslav
    Zaborska, Magdalena
    Derdakova, Marketa
    Traubner, Pavel
    NEUROENDOCRINOLOGY LETTERS, 2011, 32 (04) : 411 - 414
  • [4] Inhibition of Bruton's tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
    Torke, Sebastian
    Pretzsch, Roxanne
    Haeusler, Darius
    Haselmayer, Philipp
    Grenningloh, Roland
    Boschert, Ursula
    Brueck, Wolfgang
    Weber, Martin S.
    ACTA NEUROPATHOLOGICA, 2020, 140 (04) : 535 - 548
  • [5] Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
    Sebastian Torke
    Roxanne Pretzsch
    Darius Häusler
    Philipp Haselmayer
    Roland Grenningloh
    Ursula Boschert
    Wolfgang Brück
    Martin S. Weber
    Acta Neuropathologica, 2020, 140 : 535 - 548
  • [6] Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
    Di Pauli, Franziska
    Mader, Simone
    Rostasy, Kevin
    Schanda, Kathrin
    Bajer-Kornek, Barbara
    Ehling, Rainer
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    CLINICAL IMMUNOLOGY, 2011, 138 (03) : 247 - 254
  • [7] Tuftsin Combines With Remyelinating Therapy and Improves Outcomes in Models of CNS Demyelinating Disease
    Thompson, Kaitlyn K.
    Nissen, Jillian C.
    Pretory, Amanda
    Tsirka, Stella E.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease
    Li, Jian
    Lu, Lisen
    Binder, Kyle
    Xiong, Jian
    Ye, Lilin
    Cheng, Yan H.
    Majri-Morrison, Sonia
    Lu, Wei
    Lee, Jae W.
    Zhang, Zhihong
    Wu, Yu-zhang
    Zheng, Lixin
    Lenardo, Michael J.
    SCIENCE ADVANCES, 2023, 9 (09):
  • [9] Continuous hemifacial myokymia as the revealing symptom of demyelinating disease of the CNS
    London, Frederic
    Hadhoum, Nawal
    Zephir, Helene
    Vermersch, Patrick
    Outteryck, Olivier
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 11 : 10 - 11
  • [10] Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease
    Chastain, Emily M. L.
    Miller, Stephen D.
    IMMUNOLOGICAL REVIEWS, 2012, 245 : 227 - 238